Health

Advisory

KEY ISSUES FOR CLINICIANS CONCERNING ANTIVIRAL TREATMENTS FOR 2009 H1N1

The Delaware Division of Public Health is forwarding this Health Advisory from the Centers for Disease Control and Prevention.

Although use of influenza antiviral drugs in the United States has increased during the 2009-2010 flu season, not all people

recommended for antiviral treatment are getting treated. Listed below are important facts to consider when deciding whether a patient

needs to be treated with antiviral medication.

It is critical to remember that it is not too late to treat, even if symptoms began more than 48 hours ago. Although

antiviral treatment is most effective when begun within 48 hours of influenza illness onset, studies have shown that hospitalized

patients still benefit when treatment with oseltamivir is started more than 48 hours after illness onset. Outpatients,

particularly those with risk factors for severe illness who are not improving, might also benefit from treatment initiated more than 48

hours after illness onset.

Recommendations for Clinicians:

Many 2009 H1N1 patients can benefit from antiviral treatment, and all hospitalized patients with suspected or confirmed 2009 H1N1

should receive antiviral treatment with a neuraminidase inhibitor – either oseltamivir or zanamivir – as early as

possible after illness onset. Moderately ill patients, especially those with risk factors for severe illness, and those who

appear to be getting worse, can also benefit from treatment with neuraminidase inhibitors. A full listing of risk factors for severe

influenza is available at: http://www.cdc.gov/h1n1flu/highrisk.htm

Although antiviral medications are recommended for treatment of 2009 H1N1 in patients with risk factors for severe disease, some

people without risk factors may also benefit from antivirals. To date, 40% of children and 20% of adults hospitalized with

complications of 2009 H1N1 did not have risk factors. Clinical judgment is always an essential part of treatment decisions.

When treatment of persons with suspected 2009 H1N1 influenza is indicated, it should be started empirically. If a decision is

made to test for influenza, treatment should not be delayed while waiting for laboratory confirmation. The earlier antiviral

treatment is given, the more effective it is for the patient. Also, rapid influenza tests often can give false negative results. If you

suspect flu and feel antiviral treatment is warranted, treat even if the results of a rapid test are negative. Obtaining more accurate

testing results can take more than one day, so treatment should not be delayed while waiting for these test results. For more information

on influenza testing, please see: http://www.cdc.gov/h1n1flu/guidance/diagnostic_tests.htm.

Although commercially produced pediatric oseltamivir suspension is in short supply, there are ample supplies of children’s

oseltamivir capsules, which can be mixed with syrup at home. In addition, pharmacies can compound adult oseltamivir capsules into a

suspension for treatment of ill infants and children. Additional information on compounding can be found at: http://www.cdc.gov/H1N1flu/pharmacist/.

For More Information

Updated Interim Recommendations for the Use of Antiviral Medications in the Treatment and Prevention of Influenza for the 2009-2010

Season: http://www.cdc.gov/H1N1flu/recommendations.htm

Questions & Answers:

• Antiviral Drugs, 2009-2010 Flu Season: http://www.cdc.gov/h1n1flu/antiviral.htm
• Influenza Diagnostic Testing: http://www.cdc.gov/h1n1flu/diagnostic_testing_clinicians_qa.htm
• Updated Interim Recommendations for Obstetric Health Care Providers Related to Use of Antiviral Medications in the Treatment andPrevention of Influenza for the 2009-2010 Season: http://www.cdc.gov/H1N1flu/pregnancy/antiviral_messages.htm
• Antiviral Drugs: Summary of Side Effects: http://www.cdc.gov/flu/protect/antiviral/sideeffects.htm
• General information for the public on antiviral drugs is available in “2009 H1N1 and Seasonal Flu: What You Should Know AboutFlu Antiviral Drugs” at http://www.cdc.gov/H1N1flu/antivirals/geninfo.htm
• Downloadable brochures and informational flyers, including one on antiviral drugs, are available at http://www.cdc.gov/h1n1flu/flyers.htm
• For the FDA page on antiviral influenza drugs:http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm100228.htm

For additional information, you can also call CDC’s toll-free hotline, 800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, which is

available 24 hours a day, every day.

****

You are receiving this email because you are a registered member of the Delaware Health Alert Network.

If you are not a member and would like to subscribe, please complete the form found online at:  http://dhss.delaware.gov/main/mailforms/dph_hanform.aspx.